Navigation Links
Collagen Matrix, Inc. Launches OssiMend(TM) Bone Graft Matrix for Orthopedic and Spine Applications
Date:10/23/2007

FRANKLIN LAKES, N.J., Oct. 23 /PRNewswire/ -- Collagen Matrix, Inc. announces the launch of its OssiMend(TM) Bone Graft Matrix for orthopedic and spine applications. OssiMend is an all-natural mineral-collagen composite bone graft material which, combined with autologous bone marrow, is used to fill bony voids or gaps of the skeletal system, including spine, extremities and pelvis. OssiMend is conformable, non-friable, has a high absorption capacity, and is ideal for use in spine fusion procedures.

OssiMend is a composite matrix available in strips, pads, or granular form for surgical implantation. The principle components of OssiMend are type I collagen and anorganic bone mineral. The natural anorganic bone mineral is derived from bovine cancellous and cortical bone. Due to its natural structure, OssiMend is physically and chemically comparable to the mineralized matrix of human bone. The mineral particles are dispersed within highly purified type I collagen fibers forming a three-dimensional open porous matrix for use as an osteoconductive material. The addition of autologous bone marrow further enhances the bone forming capability of the product from bone inductive factors and bone forming cells in the bone marrow. OssiMend is provided as a sterile, dry material that is hydrated with autologous bone marrow at the point of use. OssiMend strips and pads can be cut into shapes and are designed to retain their shape and physical integrity following implantation into a bony site, while the granular form can be molded to fit the bone defect. The product is fully resorbed during the natural process of bone formation and remodeling.

"Early launch sales of OssiMend via independent sales agents have been better than expected. Feedback from surgeons has been very positive, therefore we are enthusiastic about the official launch of OssiMend at this year's North American Spine Society meeting, October 24-26, Austin, TX. Along with OssiMend, we are introducing a Multi-port Bone Marrow Aspiration Needle to aid in the harvest of autologous bone marrow. Additional products for the orthopedic-spine market, including OssiGuide(TM) Anorganic Bone Mineral Granules and DuraMatrix-Spine Onlay(TM), are planned for commercialization in the next several months." said Shu-Tung Li, Ph.D., Founder and CEO, Collagen Matrix.

About Collagen Matrix, Inc.

A Franklin Lakes, NJ based, privately-held, leading collagen- and mineral- based biomaterials company, Collagen Matrix, Inc. has applied its expertise in proprietary matrix engineering to develop and commercialize novel implants for tissue and organ repair and regeneration. The Company currently manufactures collagen- and mineral-based finished medical devices in areas of oral surgery, neurosurgery, orthopedic-spine surgery, and wound care. Over 20 products are currently being marketed directly or through partnerships with some of the world's major medical device companies. In addition to OssiMend, Collagen Matrix's marketed products include: DuraMatrix(TM) for dural repair, Neuroflex(TM), NeuroMatrix(TM) for peripheral nerve repair, Collagen Dental Membrane, Anorganic Bone Mineral, and SynOss(TM) for oral bone repair and augmentation, and the Matrix Collagen Family of Products for wound care. For more information, visit http://www.collagenmatrix.com.

Contact: Shu-Tung Li, PHD, 201-405-1477, 888-405-1001


'/>"/>
SOURCE Collagen Matrix, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Scientists find way to make human collagen in lab
2. Merge launches diagnostic mammography workstation in Europe
3. Einstein Wireless launches cellular alert system
4. Logistics Health launches compliance management tool
5. UW-Madison launches new high-speed research network
6. UWM launches research foundation
7. TeraMedica launches information manager
8. GE Healthcare launches hybrid electronic record
9. Cedara launches new version of DICOM toolkit
10. Merge launches Spanish version of imaging tool
11. Doyle launches 2025 alternative energy plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life, ... in analytical testing are being attributed to new regulatory requirements for all new ...
(Date:10/11/2017)... Alto, CA, USA (PRWEB) , ... October 11, 2017 , ... ... set to take place on 7th and 8th June 2018 in San Francisco, CA. ... policy influencers as well as several distinguished CEOs, board directors and government officials from ...
(Date:10/11/2017)... ... 11, 2017 , ... A new study published in Fertility ... fresh in vitro fertilization (IVF) transfer cycles. The multi-center matched cohort ... After comparing the results from the fresh and frozen transfer cohorts, the authors ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and ... San Diego Rotary Club. The event entitled “Stem Cells and Their ... 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter ...
Breaking Biology Technology:
(Date:4/6/2017)... LONDON , April 6, 2017 ... Control, RFID, ANPR, Document Readers, by End-Use (Transportation & ... Energy Facility, Oil, Gas & Fossil Generation Facility, Nuclear ... Healthcare, Educational, Other) Are you looking for ... Authentication sector? ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/28/2017)... India , March 28, 2017 ... IP, Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software ... Vertical, and Region - Global Forecast to 2022", published ... Billion in 2016 and is projected to reach USD ... between 2017 and 2022. The base year considered for ...
Breaking Biology News(10 mins):